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ABSTRACT The effect of peptides, corresponding to sequences in the skeletal muscle dihydropyridine receptor II-III loop,
on Ca2 release from sarcoplasmic reticulum (SR) and on ryanodine receptor (RyR) calcium release channels have been
compared in preparations from normal and malignant hyperthermia (MH)-susceptible pigs. Peptide A (Thr671-Leu690; 36 M)
enhanced the rate of Ca2 release from normal SR (SRN) and from SR of MH-susceptible muscle (SRMH) by 10  3.2
nmole/mg/min and 76  9.7 nmole/mg/min, respectively. Ca 2 release from SRN or SRMH was not increased by control
peptide NB (Gly689-Lys708). AS (scrambled A sequence; 36 M) did not alter Ca 2 release from SRN, but increased release
from SRMH by 29  4.9 nmoles/mg/min. RyR channels from MH-susceptible muscle (RyRMH) were up to about fourfold more
strongly activated by peptide A (1 nM) than normal RyR channels (RyRN) at 40 mV. Neither NB or AS activated RyRN.
RyRMH showed an 1.8-fold increase in mean current with 30 M AS. Inhibition at 40 mV was stronger in RyRMH and seen
with peptide A (0.6 M) and AS (0.6 M), but not NB. These results show that the Arg615Cys substitution in RyRMH has
multiple effects on RyRs. We speculate that enhanced DHPR activation of RyRs may contribute to increased Ca2 release
from SR in MH-susceptible muscle.
INTRODUCTION
Contraction of striated muscle depends on Ca2 release
from the terminal cisternae (TC) of sarcoplasmic reticulum
(SR) through ryanodine receptor (RyR) calcium release
channels. During excitation-contraction coupling (EC cou-
pling) in skeletal muscle, an L-type Ca2 channel (dihydro-
pyridine receptor, DHPR) senses T-tubule depolarization
and transmits an activating signal to the RyR. The signal is
transmitted via a protein-protein interaction which requires
the loop between the second and third repeats of the skeletal
DHPR 1 subunit (II-III loop, Tanabe et al., 1990). A region
important for binding of the II-III loop is located on the
skeletal RyR between Arg1076 and Asp1112 (Leong and
Maclennan, 1998). Functional interactions between the
skeletal DHPR II-III loop and skeletal RyRs have been
described. For example, the II-III loop increases [3H]ryano-
dine binding to SR vesicles, and activates purified RyR
channels in lipid bilayers (Lu et al., 1994, 1995). A short
peptide, corresponding to Thr671-Leu690 of the skeletal
DHPR II-III loop (peptide A), activates Ca2 release from
SR, (El-Hayek et al., 1995; El-Hayek and Ikemoto, 1998;
Dulhunty et al., 1999). At 40 mV, peptide A (10 nM)
activates rabbit skeletal RyRs, but at 40 mV, peptide A
(1 M) inhibits channels because the positively charged
peptide blocks the channel pore (Dulhunty et al., 1999). A
different II-III loop peptide, peptide C (724–760) inhibits
activation of Ca2 release from SR by peptide A (El-Hayek
et al., 1995; El-Hayek and Ikemoto, 1998).
Because of the ability of the skeletal II-III loop and
peptide A to activate RyRs, it has been suggested that
binding of the A region of the DHPR to the RyR is a step in
EC coupling (El-Hayek et al., 1995; El-Hayek and Ikemoto,
1998). Although the A region peptide is undeniably a high
affinity activator of the RyR, its precise role in EC coupling
remains to be determined. Skeletal EC coupling occurs
when the A region contains either a skeletal, cardiac, or
scrambled sequence; skeletal EC coupling cannot proceed
unless the II-III loop contains a skeletal sequence between
residues 725 and 742 (Nakai et al., 1998; Proenza et al.,
2000), which is encompassed in peptide C. Curiously, the
cardiac DHPR II-III loop also increases the activity of
skeletal RyRs (Lu et al., 1994, 1995). Therefore, perhaps
not surprisingly, binding of the II-III loop, or the 20-amino
acid peptide A, has less rigid isoform specificity than the
full EC coupling process. The experiments with dysgenic
myocytes (Nakai et al., 1998; Proenza et al., 2000) do not
give quantitative or kinetic information about EC coupling.
It is possible that signal transmission during normal skeletal
EC coupling occurs through both the A and C regions, but
that some Ca2 release from the SR can be induced via the
C region alone. The functional properties of the A peptide
continue to be investigated (i) because it is a high affinity
specific activator of the RyR and thus useful for probing
RyR function and (ii) because the A region may play a role
in EC coupling.
The skeletal RyR is altered in a potentially lethal manner
by approximately half of the mutations that lead to suscep-
tibility to malignant hyperthermia (MH; Loke and Maclen-
nan, 1998; Jurkat-Rott et al., 2000). In humans, 22 MH
mutations have been identified at 20 different amino acid
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residues in the RyR and two MH mutations at one residue in
the DHPR (Jurkat-Rott et al., 2000). A single amino acid
substitution of Arg614 to Cys is responsible in 4% of MH-
susceptible humans, and the same substitution at residue
615 of the RyR is found in all MH-susceptible pigs. Fifteen
MH-linked RyR mutations are associated with an increased
sensitivity to caffeine-induced Ca 2 release when recom-
binant DNA for the mutant RyRs was expressed in heter-
ologous systems (Tong et al., 1997). Only two identified
mutants have been studied in detail in muscle cells and/or
muscle-derived preparations: arg615cys in pigs and
gly2434arg in humans. A comparison of these mutants dem-
onstrated remarkable similarities in RyR abnormalities, in-
cluding enhanced sensitivity to both caffeine and calcium
(Richter et al., 1997). Porcine MH SR vesicles are charac-
terized by a greater than normal rate of Ca2-induced Ca2
release (Kim et al., 1984); MH RyR channels have reduced
inhibition by millimolar concentrations of Ca2 (Fill et al.,
1991; Shomer et al., 1993) or Mg2 (Laver et al., 1997).
Both of these abnormalities would presumably lead to en-
hanced Ca2 release from SR during EC coupling (Ohta et
al., 1989) and increased force production (Gallant et al.,
1980) in MH muscles. Whether or not resting cytoplasmic
[Ca2] is increased in MH muscles remains controversial
(Mickelson and Louis, 1996), and resting [Ca2] is not
elevated when RyRs with MH mutations are expressed in
heterologous systems (Otsu et al., 1994; Tong et al., 1997,
1999). Such an elevation could indicate greater than normal
Ca2 leak from the SR of MH-susceptible muscles.
It has been suggested that reduced Mg2 inhibition could
be responsible for a higher resting cytoplasmic [Ca2] and
enhanced EC coupling in muscle from MH-susceptible pigs
(Laver et al., 1997). It is thought that RyRs are chronically
inhibited by Mg2 under resting conditions, and EC cou-
pling proceeds after a decrease in the affinity of RyRs for
Mg2 (Lamb and Stephenson, 1991). Although the reduced
Mg2 inhibition explains many of the effects of the
Arg615Cys substitution on EC coupling, other aspects of
RyRMH activity relevant to EC coupling have not been
examined. Therefore, we have compared the effects of
peptide A on the activity of normal RyRs and on RyRs from
MH-susceptible pig muscle.
We find that peptide A activation of Ca2 release from
SR of MH-susceptible pigs is eightfold greater than that
from SR of normal pigs. The enhancement of single RyR
channel activity, at 40 mV, by peptide A is also two- to
fourfold greater in RyRMH as compared to RyRN. This
activation is specific for the native sequence of peptide A.
Activation is not seen with peptide NB, corresponding to a
sequence in a different region of the skeletal II-III loop,
whereas lesser activation is seen with a scrambled sequence
of the peptide (peptide AS). Inhibition of RyR channels at
40 mV by peptide A and peptide AS is also enhanced in
RyRMH. The results show that the point mutation in MH can
have multiple effects on RyR activity. It is possible that
stronger binding of the peptide A region of the DHPR to the
RyRMH may contribute to greater Ca
2 release from the SR
during EC coupling in MH-susceptible muscle.
METHODS
Materials
Chemicals and biochemicals were from Sigma-Aldrich (Castle Hill, Aus-
tralia). DHPR II-III loop peptide synthesis has been described previously
(Dulhunty et al., 1999). Peptides were synthesized with purification to 98
to 100% using HPLC, mass spectroscopy, and NMR. Stock peptide solu-
tions (2 mM) were prepared in H2O and frozen in aliquots of 20 l.
Precise stock solution concentrations were determined by Auspep Propri-
etry Ltd. (Melbourne, Australia). Peptides used in this study were:
Peptide A:
671Thr Ser Ala Gln Lys Ala Lys Ala Glu Glu Arg Lys Arg Arg Lys Met Ser
Arg Gly Leu690
Peptide NB:
689Gly Leu Pro Asp Lys Thr Glu Glu Glu Lys Ser Val Met Ala Lys Lys
Leu Glu Gln Lys708
Peptide AS:
Thr Arg Lys Ser Arg Leu Ala Arg Gly Gln Lys Ala Lys Ala Lys Ser Glu
Met Arg Glu
Biological material and caffeine-halothane
contracture test for MH susceptibility
The methods for genetic testing, anaesthetic techniques, muscle dissection,
caffeine-halothane contracture testing, preparation of SR vesicles, and
single channel recording have been described previously (Otsu et al., 1992;
Owen et al., 1997; Laver et al., 1997). Muscle and blood samples were
obtained from 3 homozygous normal pigs (1 Belgium Landrace and 2
Landrace) and 3 homozygous MH pigs (2 Belgium Landrace and 1 Land-
race) aged 4 months. Each animal was genetically tested for normal or
MH RyR allele containing either Arg615 or Cys615. The SR preparations
were from the same animals as those used in Laver et al. (1997) and
Haarmann et al. (1999). All fiber bundles from the 3 homozygous normal
animals failed to respond to halothane or 2 mM caffeine, whereas all fiber
bundles from the 3 homozygous MH animals developed tension in re-
sponse to both drugs.
Isolation of SR vesicles
The preparation of crude SR vesicles was based on Meissner (1984) and
Ma et al. (1995). Freshly dissected back and leg muscle was washed in cold
phosphate-buffered saline containing 2 mM EGTA (pH 7.0), trimmed of
fat and connective tissue, cut into cubes, and either frozen in liquid N2 and
stored at 70°C or freshly processed. The fresh or thawed muscle cubes
were suspended in 5 mM Tris maleate, 100 mM NaCl, 2 mM EDTA, and
0.1 mM EGTA, pH 6.8 (5 ml/g of tissue). The muscle was homogenized in
a Waring Blendor with four 15-s high-speed bursts. The homogenate was
centrifuged at 2600  g for 30 min and the supernatant filtered through
cotton gauze and centrifuged at 10,000 g for 30 min. The pellet (P2) was
collected and the supernatant was centrifuged again at 35,000  g and the
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pellet (P3) collected. Pellets P2 and P3 were resuspended in 5 mM
Tris-2-(N-morpholino)ethanesulphonic acid (Tris-MES), 300 mM sucrose,
100 mM KCl, and 2 mM dithiothreitol, pH 6.8. Aliquots of the suspensions
were frozen in liquid nitrogen and stored at 70°C. All buffers contained
the protease inhibitors phenylmethylsulfonyl fluoride (0.7 mM), leupeptin
(1 g/ml), pepstatin A (1 M), and benzamidine (1 mM).
Calcium release from SR vesicles
Extravesicular Ca2 was monitored at 710 nm with the Ca2 indicator,
antipyrylazo III, using a Cary 3 Spectrophotometer (Varian, Sydney, Aus-
tralia). Identical experiments at 790 nm showed that there were no changes
in OD which would alter the rate of Ca2 uptake measured at 710 nm. A
step increase in OD upon addition of ruthenium red or caffeine, seen at
both 710 nm and 790 nm, was subtracted from the data in Figs. 1 and 2
(Results). The temperature of the cuvette solution was thermostatically
controlled at 25°C, and the solution was stirred with a magnetic stirrer.
Ca2 release was measured as described by Timerman et al. (1993). TC
vesicles (100 g of protein) were added to the cuvette, to a final volume
of 2 ml of a solution containing 100 mM KH2PO4 (pH 7); 4 mM MgCl2,
1 mM Na2ATP, and 0.5 mM antipyrylazo III. Vesicles were partially
loaded with Ca2 by four sequential additions of CaCl2, each initially
increasing the extravesicular [Ca2] by 7.5 M (15 nmoles). It was
necessary to suppress Ca2, Mg2-ATPase activity after loading (using
200 nM thapsigargin; Sagara and Inesi, 1991), to allow extravesicular
[Ca2] to increase after activation of the RyR. Peptide was then added,
followed either by 10 mM caffeine (to determine RyR-releasable Ca2
remaining in the SR vesicles) or by the RyR blocker ruthenium red (to a
final concentration of 5 M), to determine whether Ca2 release from SR
was via RyR channels. The Ca2 ionophore A23187 (3 g/ml) was finally
added to release the Ca2 remaining in the SR vesicles. A calibration curve
for OD changes for a given increase in [Ca2] was established at the start
of each experiment, using 4 sequential additions of 12.5 M (25 nmoles)
of CaCl2.
Addition of H2O alone to the cuvette after thapsigargin, produced a
small decline in the rate of release of Ca2. This was measured for each
experiment and the rate of Ca2 release in the presence of peptide was
appropriately corrected. The increase in OD for a given increase in ex-
travesicular [Ca2] was 40% less in the presence of 10 mM caffeine (see
legend to Fig. 1). This factor was taken into account in calculations of
releasable Ca2.
Lipid bilayer techniques
The lipid bilayer and single channel recording technique are described in
Laver et al. (1997) and Dulhunty et al. (1999). Bilayers were formed from
phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine
(5:3:2 w:w) (Avanti Polar Lipids, Alabaster, AL) across an aperture with a
diameter of 200 to 250 m in the wall of a 1.0 ml Delrin cup (Cadillac
Plastics, Australia). TC vesicles (final concentration, 10 g/ml) were added
to the cis chamber and stirred until vesicle incorporation was observed. The
cytoplasmic side of channels incorporated into the bilayer faced the cis
solution. The bilayer potential was controlled, and single channel activity
was recorded using an Axopatch 200A amplifier (Axon Instruments, Foster
City, CA). For experimental purposes, the cis chamber was held at ground
and the voltage of the trans chamber controlled. Bilayer potential is
expressed in the conventional way as Vcis  Vtrans, (i.e., Vcytoplasm 
Vlumen).
Bilayers were formed and vesicles incorporated into the bilayer using
cis solutions containing 230 mM Cs methanesulphonate (CsMS), 20 mM
CsCl, 1.0 mM CaCl2, and 10 mM N-tris[hyroxymethyl]methyl-2-amin-
oethanesulfonic acid (TES), pH 7.4, adjusted with CsOH. The trans solu-
tion had the same composition, except that CsMS was 30 mM. The cis
solution sometimes contained 500 mM mannitol to aid SR vesicle fusion
and RyR incorporation into the bilayer. After incorporation, the cis solution
was replaced (by perfusion) with an identical solution, except that [Ca2]
was varied between 0.3, 10, and 100 M, and buffered at 0.3 and 10 M
by 2 mM BAPTA, and 200 mM CsMS was added to the trans chamber to
establish symmetrical conditions.
Recording and analysis of single channel activity
Currents were filtered at 1 kHz (10-pole low pass Bessel, 3dB) and
digitized at 5 kHz. Analysis of single channel records (using Channel 2,
developed by P. W. Gage and M. Smith, John Curtin School of Medical
Research) yielded channel open probability (Po), frequency of events (Fo),
open times, closed times, and mean open (To) and closed (Tc) times, as well
as mean current (I). Po, To, and Tc were measured by determining the
number and duration of events in which the current exceeded a threshold
level. An event discriminator set above the baseline noise at 20% of the
FIGURE 1 Increase in rate of Ca2 release after addition of peptide A is
greater in SRMH than in SRN. (A) and (B) show records of OD changes at
710 nm, with changes in extravesicular [Ca2], measured using antipyry-
lazo III as the Ca2 indicator. SR vesicles were loaded with Ca2 by an
initial uptake of 16 nmoles of Ca2 plus four additions of 15 nmoles of
Ca2 (not shown). The first arrow (t) indicates addition of 200 nM
thapsigargin to block the SR Ca2 ATPase. The second arrow (p) indicates
addition of 36 M peptide A. Caffeine (10 mM) was added at the third
arrow (c) before the ionophore A23187 (last arrow (i), 3 g/ml). The
vertical calibration is in OD units: an increase of 0.1 OD unit occurred with
an increase in extravesicular Ca2 of 18 nmoles before adding caffeine, or
31 nmoles after adding caffeine (see Methods). Ca2 is the non-RyR
releasable Ca2 remaining in the SR after exposure to caffeine.
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maximum current, rather than the usual 50%, was used so that openings to
both subconductance and maximum conductance levels were included in
the analysis. In contrast, I, the mean current, is the average of all data
points in a record, in which the baseline is set to 0 pA. Ideally, in a channel
lacking submaximal conductance activity, I approaches the single channel
conductance as Po approaches 1.0. The threshold detection method is very
accurate in measuring openings when the peak amplitude of openings
exceeds the event discriminator. However, the technique fails when the
channel openings are to low conductance levels that are close to the
baseline noise. In this case, mean current provides the most accurate
method of measuring channel activity.
Bilayers that appeared to contain one channel under control conditions
often showed multiple channel openings (i.e., a maximum conductance of
2 or 3 times the single channel conductance) after addition of peptide A. I
provided an accurate measure of the current flowing through two or three
channels after addition of peptide. The discriminator method was not used
to measure activity when more than one channel was present in the bilayer
because of the difficulty in deconvolution to meaningful single channel
parameters. Since bilayers containing more than one channel could not be
used for measurements of single channel parameters (i.e., Po, To, and Tc)
and since most bilayers eventually contained more than one channel,
routine measurements of channel activity were done using mean current
(I) analysis. Po was measured in the few records containing only one
channel to assess how single channel activity was affected by the peptide.
Statistics
Average data is given as mean  SEM. The significance of the difference
between control and test values was tested a using either Student’s t-test,
either 1- or 2-sided and either for independent or paired data, as appropri-
ate, or the nonparametric sign test (Minium et al., 1993). Differences were
considered to be significant when P  0.05.
RESULTS
Calcium release from sarcoplasmic
reticulum vesicles
Ca2 release from skeletal SR of normal (SRN) and MH-
susceptible (SRMH) pig muscle was examined in vesicles
that were loaded with Ca2 followed by block of the Ca2,
Mg2-ATPase with 200 nM thapisgargin. A time-depen-
dent increase in extravesicular [Ca2] occurred after thap-
sigargin addition. The rate of calcium release increased
further after adding peptide A (Fig. 1).
In the examples in Fig. 1, the rate of Ca2 release from
SRN with thapsigargin was 47 nmoles/mg/min and this
increased to 60 nmoles/mg/min after adding 36 M pep-
tide, showing a peptide-induced enhancement of 13 nmoles/
mg/min (Fig. 1 A). Peptide A evoked stronger release from
SRMH; the rate increased from 66 nmoles/mg/min with
thapsigargin to 162 nmoles/mg/min after adding 36 M
peptide, with a peptide-induced enhancement of 96 nmoles/
mg/min (Fig. 1 B).
The fraction of Ca2 accumulated by SRN and SRMH that
was not available for release through RyRs (presumably that
not contained in terminal cisternae) was determined by
exposing vesicles to 10 mM caffeine (4 min after peptide
addition), to release Ca2 in TC vesicles through RyR
channels, and then to the Ca2 ionophore A23187 (3 g/ml)
to release all remaining Ca2 (Fig. 1, A and B). The fraction
of non-releasable Ca2 was the difference between the
Ca2 released by caffeine and that released by the iono-
phore (Ca, Fig. 1; Ca is larger in SRMH than in SRN).
Ruthenium red (10 M) stopped Ca2 release if it was
added while extravesicular [Ca2] was increasing (n 	 8,
data not shown), showing that Ca2 release after addition of
thapsigargin, and release activated by peptide A, was
through RyR channels.
On average the rate of Ca2 release from SRMH with
thapsigargin of 53  5.2 nM/mg/min (n 	 12) was signif-
icantly greater than the 41  2.2 nM/mg/min (n 	 13) for
SRN. The rate of Ca
2 release induced by peptide A is the
rate after peptide addition, minus the rate with thapsigargin
(inset, Fig. 2). A release rate of 76  9.7 nmole/mg/min
(n 	 3) from SRMH induced by 36 M peptide A was
significantly greater than the rate of 10 3.2 nmole/mg/min
from SR N (n 	 3, Fig. 2). Comparable results were ob-
tained from three SRN and three SRMH preparations.
Average nonreleasable Ca2 was 16.5  0.57 nmoles in
SRN and 20.3  0.55 nmoles in SRMH. Since 60 nmoles
of Ca2 were loaded, non-RyR releasable Ca2 fraction was
0.28  0.01 in RyRN and 0.34  0.01 in RyRMH. The
significantly smaller nonreleasable Ca2 in SRN suggests
that SRN was more enriched in terminal cisternae than the
SRMH. The different fraction of nonreleasable Ca
2 indi-
cated that the difference between peptide A-induced release
from terminal cisternae was about eightfold greater in SRMH
than in SRN (rather than the 7.6-fold indicated by the
uncorrected rates).
Control peptides NB and AS did not mimic the effects of
peptide A. The rates of Ca2 release from SRN and SRMH
FIGURE 2 The initial rate of peptide A-enhanced Ca2 release
(nmoles/mg of TC vesicles/min) from SRN is less than from SRMH. The
rate is the initial rate of release with peptide, minus the preceding rate with
thapsigargin (n 	 3 at each peptide concentration for each of SRN and
SRMH). Filled bins show data from SRN and cross-hatched bins show data
for SRMH. Data are averages  SEM for TC vesicles from three different
SR preparations. Asterisks show significant differences between data for
SRN and SRMH. The insert shows average rates of Ca
2 release from SRN
and SRMH in the presence of thapsigargin, just before addition of peptide
(n 	 12).
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immediately after adding 36 M NB (minus the rate with
thapsigargin) were 8.2  2.6 nmoles/mg/min (n 	 4) and
1.1  3.4 nmoles/mg/min (n 	 4), respectively. Addition
of AS resulted in excess release at rates of 6.3  4.2
nmoles/mg/min (n 	 4) and 29  4.9 nmoles/mg/min (n 	
4) for SRN and SRMH, respectively. The increase in Ca
2
release from SRMH with AS was significant, but remained
significantly less than that induced by peptide A.
RyR channel activity
Peptide A (0.6 nM to 30 M) was added to the cis side of
the bilayer, with 250/250 mM Cs (cis/trans), at [Ca2]s of
3 107 M, 105 M, or 104 M (cis) and 103 M (trans).
Initial experiments with 2 mM Na2ATP in the cis solution
failed to show convincing peptide A-induced activation of
normal pig skeletal RyRs (RyRN, n 	 23) or RyRs from
MH-susceptible pigs (RyRMH, n 	 25), although the usual
peptide A-induced inhibition (Fig. 6 below) was seen in the
presence cis Ca2 	 100 M. Thus experiments examining
activation by peptide A were performed in the absence of
ATP. Low levels of activity were recorded under these
conditions. Table 1 shows that average mean current in
bilayers containing 1 to 3 RyRN or RyRMH channels was
between 0.2 and 2.5 pA before addition of peptide. This was
0.01 to 0.05 of the maximum current (15 pA or 15 pA
at 40 mV or 40 mV, respectively). There were no
significant differences in control mean current between
RyRN and RyRMH.
Activating effects of peptide A on channels at
40 mV
The strongest activating effects of peptide A in rabbit are
seen at negative potentials where there is less peptide-
induced inhibition (Dulhunty et al., 1999). Peptide A (cis,
0.6 M and 30 M) activated RyRN and RyRMH channels
at 40 mV (Fig. 3). The increase in activity was not
associated with an increase in the single channel conduc-
tance. The conductance of the RyRN channel was in fact
reduced with 30 M peptide, due to the peptide’s inhibitory
action. One RyRMH channel is apparent in Fig. 3 under
control conditions and a second and third channel are seen
with peptide A. Washout of peptide with 10 volumes of cis
solution caused an increase in activity (discussed below).
Activity of RyRN and RyRMH was abolished by 30 M cis
ruthenium red added at the end of the experiment (Fig. 3 G).
A history plot of mean current during similar experiments
with 10 or 100 M cis Ca2 are shown in Fig. 4. I
progressively increased during exposure to increasing con-
centrations of peptide and there was a further increase after
washing out 30 M peptide. A greater increase in activity
with peptide addition is seen in RyRMH than in RyRN. The
average normalized mean current (Ip/Ic) also increased
TABLE 1 Average mean current under control conditions
(Ic) in pA for RyRN and RyRMH with 300 nM, 10 M, and
100 M cis Ca2
Cis[Ca2]
RyRN RyRMH
n
40mV
Ic (pA)
40mV
Ic (pA) n
40mV
Ic (pA)
40mV
Ic (pA)
300 nM 8 0.68  0.21 0.67  0.24 9 0.94  0.29 0.94  0.50
10 M 8 1.16  0.17 1.22  0.30 10 1.77  0.85 1.24  0.44
100 M 6 1.76  0.4 1.62  0.41 6 1.33  0.26 2.48  0.98
Data are given as mean  SEM. The number of experiments is listed under
n. The data in bold print are significantly different (Student’s t-test from
data obtained with 300 nM cis Ca2.
FIGURE 3 Single channel activity at 40 mV is enhanced after adding
0.6 M or 30 M peptide A and activation is greater in RyRMH (right
panel) than RyRN (left panel). Records were obtained with 10 M cis
Ca2. (A) Control; (B) after adding 0.6 M peptide A to the cis chamber;
(C) after increasing cis (peptide A concentration) to 30 M; (D–F), 1, 8,
and 12 min, respectively, after perfusion of the cis chamber with peptide-
free solution; (G) 1 min after adding 30 M cis ruthenium red. The solid
line shows the zero current (closed, C); the broken line shows the maxi-
mum open channel conductance for one channel (O1), or two channels
(O2) in RyRMH.
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more in RyRMH than in RyRN with peptide A at each cis
[Ca2] (Fig. 5, A–C). Maximum activation of both RyRN
and RyRMH at was achieved with 0.6 to 6 M peptide A.
Single channel parameters were measured from records
with only one channel active in the bilayer before and
during exposure to the peptide (Fig. 6). Such experiments
were rare because summed openings of multiple (two or
three) channels usually became obvious after addition of
activating concentrations of peptide. Therefore, the numbers
of channels analyzed in this way were too few to establish
the Ca2 dependence of single channel parameters or the
effects of Ca2 on peptide-induced changes in the parame-
ters. The effects of cytoplasmic Ca2 concentration on
peptide A-induced activation are best seen in Fig. 5.
In the set of experiments used for single channel analysis,
activity tended to be low (Po 
 0.1) under all control
conditions. Peptide A caused an increase in Po, To, and Fo
and a decrease in Tc in all 7 RyRN channels and in 8 of 9
RyRMH channels at 40 mV (Fig. 6, A–D). There was no
consistent difference between parameter values for RyRN
and RyRMH under control conditions at 100 M cis Ca2
(see also Fill et al., 1990; Shomer et al., 1993; Laver et al.,
1997). However, in the presence of the peptide at 40 mV,
Po, and To tended to be greater in RyRMH than in RyRN
(Fig. 6, A and B).
Overall, the results suggest that peptide A had similar ac-
tions on the gating of RyRN and RyRMH channels, reducing the
mean closed time and increasing the duration and frequency
of channel openings. The effect of the Arg615Cys substitu-
tion in RyRMH was to amplify these actions of the peptide,
particularly the increase in the duration of channel opening.
Activating and inhibiting effects of peptide A on
RyR channels at 40 mV
At 40 mV, RyRN and RyRMH channels were activated by
peptide A at 0.6 M, but inhibited by peptide at 30 M
FIGURE 4 Continuous time course of channel activity during exposure
to peptide A, washout of peptide A and exposure to ruthenium red. The
mean current (I) in 30-s recordings at 40 mV (each separated by a 30-s
recording at 40 mV). A and IB, with 100 M cis Ca2; data from one
bilayer with 2 RyRN (open circles) and a second bilayer with 2 RyRMH
channels (filled circles). C and D, with 10 M cis Ca2; data from one
bilayer with 2 low activity RyRN channels (open circles) and from a second
bilayer with 3 relatively high activity RyRMH (filled circles), to compare
analysis techniques. Each data point is from a 30-s recording at 40 mV.
Successive points are separated by 30 s at40 mV (not shown). The initial
two points in each graph show control activity. Peptide A was then added
to progressively increase concentration from 0.6 nM to 6 nM, 60 nM, 600
nM, 6 M, and 306 M (indicated by short horizontal lines), with 120 s at
each peptide concentration. Peptide was then perfused out of the cis
chamber and washout effects recorded during the period labeled “wash”.
Finally, ruthenium red was added (horizontal line labeled r).
FIGURE 5 Peptide A causes a greater increase in mean current at 40
mV in RyRMH (right) than in RyRN (left). Relative mean current (Ip/Ic,
where Ip is I in the presence of peptide and Ic is I under control
conditions) is plotted against the logarithm of peptide A concentration in
nM. Symbols show average Ip/Ic and vertical bars show 1 SEM where
this is greater than the dimensions of the symbol. Results were obtained
with: (A) 300 nM cis Ca2 (n 	 11 for RyRN; n 	 8 for RyRMH); (B) 10
M cis Ca2 (n	 19 for RyRN; n	 15 for RyRMH); (C) 100 M cis Ca2
(n 	 9 for RyRN; n 	 10 for RyRMH).). On average, peptide A caused up
to a twofold increase in Ip/Ic for RyRN at each cis [Ca2]. RyRMH
showed greater increases in the normalized mean current at 40 mV with
peptide A at each cis [Ca2], with 4.0- to 7.5-fold increases in Ip/Ic.
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(Fig. 7, A–C). Inhibition resulted in channel openings to
lower conductance levels, which are apparent in RyRN with
0.6 M peptide (Fig. 7 B). Activation by 0.6 M peptide at
40 mV was greatest in the RyRMH channel. Perfusion of
peptide A out of the cis chamber at 40 mV was followed
by a slow increase, and then a decline in channel opening
(Fig. 7, D–F). The increase in activity after perfusion was
associated with recovery of the maximum open conduc-
tance, confirming that the reduced conductance with 0.6
M peptide was due to the inhibitory effect of the peptide.
Normalized mean current at 40 mV increased with
peptide A between 0.6nM and 0.6 M and then, in contrast
to effects at 40 mV, declined with inhibition at higher
[peptide] under most conditions (Fig. 8). Both the increase
in average Ip/Ic and the subsequent decline with increas-
ing [peptide] at 40 mV were more pronounced in RyRMH
than in RyRN. As in rabbit (Dulhunty et al., 1999) the
strongest inhibition by peptide A was seen in both RyRN
and RyRMH when cis Ca2 was 100 M.
The peptide-induced changes in single channel parame-
ters were smaller and less consistent at 40 mV than at
40 mV (Fig. 6, E–H). For example, an increase in To was
seen in 5 of 7 RyRN channels and 3 of 9 RyRMH channels.
FIGURE 6 The effects of peptide A on single channel characteristics of
RyRN and RyRMH. Analysis was performed on 120 s of channel activity
before addition of peptide and 120 s of activity at the peptide concentration
giving greatest activation, i.e., between 0.6 and 30 M. Channel activity
was measured at40 mV (A–D) and at40 mV (E–H). Data is shown for
open probability (Po, A and E), mean open time (To, B and F), opening
frequency (Fo, C and G) and mean closed time (Tc, D and H). The symbols
show data for individual channels with cis Ca2 concentrations of 300 nM
(E), 10 M (f), and 100 M (F). Solid lines connect data for control
conditions (con) with data obtained in the presence of peptide A (A).
FIGURE 7 Single channel activity at 40 mV is enhanced after adding
0.6 M peptide A, but is inhibited with 30 M peptide A. Activation is
greater in RyRMH (right panel) than RyRN (left panel). Records are from
the same channels shown in Fig. 3 with 10 M cis Ca2. (A) control; (B)
after adding 0.6 M cis peptide A; (C) after increasing cis [peptide A] to
36 M; (D–F), 1, 8, and 12 min, respectively, after perfusion of the cis
chamber with peptide-free solution; (G) 1 min after adding 30 M ruthe-
nium red to the cis chamber. The solid line shows the zero current (closed,
C); the broken line shows the maximum open single channel conduc-
tance (O).
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This was presumably due to the competing activating and
inhibiting effects of the peptide at40 mV, since inhibition
decreases To (Dulhunty et al., 1999).
Peptide A washout
The increases in channel activity after washout of peptide
(Figs. 3, 4, and 7) were also seen in rabbit RyRs and were
thought to reflect exposure of a high-affinity activating
effect after washout of a lower affinity peptide A-induced
inhibition (Dulhunty et al., 1999). The slower removal of
peptide from its activating site after washout is consistent
with a higher affinity binding to the activation site in RyRN
and RyRMH, whereas faster removal from the inhibition site
is consistent with lower affinity binding to the inhibition site
in RyRN and RyRMH. The washout activation suggests that
channel activity in the presence of the peptide is a sum of
simultaneous activation and inhibition. The time to peak
activity after washout reflects the time course of removal of
inhibition. The lack of full reversal of activation after 7 to
12 min suggests that the peptide remained bound to its
activation site for this time, as might be expected with high
affinity binding. The slower washout of activation in
RyRMH suggests stronger binding of peptide A to the acti-
vation site on RyRMH.
The increase in RyR activity after removal of peptide A
may provide a more accurate indication of the ability of the
peptide to activate RyRN and RyRMH than channel activity
in the presence of the peptide, which is the sum of activation
and inhibition. Long-term washout experiments were per-
formed with 10 M and 100 M cis Ca2. Ip/Ic increased
significantly after washout and was significantly greater at
40 mV than at 40 mV under all conditions (Fig. 9).
Ip/Ic after washout at40 mV was significantly greater in
RyRMH than in RyRN with both 10 M and 100 M cis
Ca2 (note the different scales on the y axes). Curiously,
there was no difference between RyRN and RyRMH in
FIGURE 8 Peptide A causes a greater decrease in average mean current
at 40 mV in RyRMH (right column) than in RyRN (left column). Relative
mean current is plotted as described for Fig. 5. Symbols show average
Ip/Ic and vertical bars show 1 SEM where this is greater than the
dimensions of the symbol. Results were obtained with: (A) 300 nM cis
Ca2 (n 	 11 for RyRN; n 	 8 for RyRMH); (B) 10 M cis Ca2 (n 	 19
for RyRN; n	 15 for RyRMH); (C) 100 M cis Ca2 (n	 9 for RyRN; n	
10 for RyRMH). There were 3.4-fold and 5.0-fold declines in average
Ip/Ic, from the maximum peptide-activated levels, in RyRMH with 30 M
peptide and 10 M or 100 M cis Ca2 respectively, compared with
2.1-fold and 1.6-fold falls in Ip/Ic for RyRN. Ip/Ic did not fall signifi-
cantly in RyRN with 300 nM Ca
2.
FIGURE 9 Mean current increases after peptide A removal from the cis
chamber. The increase is significantly greater at 40 mV in RyRMH (right
panel) than in RyRN (left panel) at each cis [Ca2] (note the different scales
on the y axes; see text). The results are from a subset of data in which RyRN
or RyRMH channels were held for 6 to 10 min after washout of peptide A,
with 10 M cis Ca2 (n 	 6 for RyRN; n 	 5 for RyRMH) (A) or 100 M
cis Ca2 (n	 6 for RyRN; n	 8 for RyRMH) (B). The [Ca2] was the same
in the peptide-containing solution and the perfusion solution. Filled bins,
Ip/Ic (see legends to Figs. 5 and 6, for definition) during exposure to 30
M peptide A. Cross-hatched bins, Ip/Ic for 60 s of maximum activity,
6 to 8 min after washout of peptide A. The asterisks indicate that the
difference between Ip/Ic before and after peptide removal is significant
according to the Student’s t-test. The hatch marks (#) indicate the differ-
ence is significant according to the nonparametric sign test. Results are
shown for 40 mV and 40 mV as indicated.
1776 Gallant et al.
Biophysical Journal 80(4) 1769–1782
Ip/Ic after washout at 40 mV. This may have been due
to slower removal of the stronger inhibition of RyRMH
Washout activation provides minimum values for the
effectiveness of the peptide in activating RyRs, since max-
imum Ip/Ic occurred when some inhibition remained and
activation was declining. Slower washout of inhibition in
RyRMH would further reduce the observable activation for
these channels. The greatest average activation was a sev-
enfold increase in Ip/Ic in RyRN and an 11-fold increase in
RyRMH (with 10 M cis Ca2). Highest individual values
were a 12-fold increase in one RyRN channel and a 15-fold
increase in one RyRMH.
Control experiments
Three types of control experiment for the effects of peptide
A and its removal on RyR activity are shown in Fig. 10. In
the first type of experiment (Fig. 10, A and B), bilayers were
exposed to one concentration of peptide (30 M) for 20
min. There was a slow increase in activity during the 20 min
of exposure to the peptide in RyRN and RyRMH, with a
greater increase in RyRMH. The small increase in activity
during exposure to peptide was followed by a massive
increase upon washout. Similar results were obtained in 5
bilayers containing RyRMH and 3 bilayers containing RyRN
channels. Fig. 10, A and B, show examples of washout
effects with 300 nM cis Ca2 (not shown in Fig. 9 above)
and also show that the washout-induced increase in activity
after 20 min exposure to 30 M peptide was similar to that
after 2 min exposure to 30 M peptide, with a total expo-
sure to increasing peptide concentration of 12 min (Fig. 4
above). Thus, the increase in activity after 12 min was a
specific effect of washout and not a function of time after
exposure to peptide.
In the second type of experiment the volumes of water
normally added with peptide were added at the usual inter-
vals, but in the absence of peptide, and then the cis chamber
perfused (Fig. 10, C and D, circles). Finally, in the third type
of experiment, the cis solution was stirred at 2min intervals,
with no additions, and then perfused after 12 min (Fig. 10 D,
triangles). There was no significant increase in RyRN activ-
ity with water or with stirring alone. Neither did activity
increase in RyRN after perfusion. There was a consistent
approximately twofold increase in I in RyRMH after the
second perfusion of the cis solution in RyRMH, after either
water addition or stirring alone (all experiments were pre-
ceded by a perfusion step to replace the incorporation so-
lution with the recording solution; see Methods). The in-
crease after the second perfusion was small compared with
the increase in activity after washout of peptide. Similar
results were obtained for the water control in 4 bilayers
containing RyRN and 10 bilayers containing RyRMH, and
for the stirring controls in 3 bilayers containing RyRMH.
Fig. 10, C and D, shows that the increase in activity during
exposure to the peptide and upon its washout are specific
effects of peptide A on channel activity, since they do not
occur in the absence of peptide.
FIGURE 10 A large increase in channel activity upon washout of pep-
tide A occurs after 20 min exposure to 30 M peptide and is not seen
unless channels have been exposed to peptide. Analysis of continuous
channel activity in 30-s segments at 40 mV (each separated by a 30-s
recording at 40 mV), recorded with 300 nM cis Ca2. The data in A and
B were from a single RyRN (A) and a single RyRMH channel (B), under
control conditions (first 3 points), during exposure to cis peptide for 20 min
(30 M, A1), and after perfusion of the cis chamber (wash) and then
exposure to ruthenium red (r). The data in C were obtained from a bilayer
containing two RyRN channels, under control conditions (first 4 points)
during exposure to increasing volumes of water (0.5, 4.5, 4.5, 4.5, 4.5, and
20 l, equivalent to that added with stock solutions to give 0.6 nM, 6 nM,
60 nM, 0.6 M, 6 M, and 30 M peptide, respectively), and then after
perfusion of the cis chamber. The data in D were from three different
bilayers containing RyRMH channels. The open circles show data from one
bilayer containing three channels and the filled circles show data from a
second bilayer containing one channel. The first two or three data points were
obtained under control conditions; data were then obtained with water addi-
tions (as above) and after perfusion of the cis chamber, and finally after
addition of ruthenium red (r). In the third experiment (D, ‚), data are shown
from one channel under control conditions (first 3 points), and then during a
12-min period during which the cis solution was stirred every 2 min, but no
additions were made to the solution. Perfusion was performed in the usual way
after 12 min, and ruthenium red was added at the end of the experiment.
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Long-lasting substate openings induced by
peptide A
Channel opening to lower conductance levels as a result of
the inhibitory action of peptide A was seen in all channels.
Very long lasting substate openings (Tripathy et al., 1998;
Gurrola et al., 1999) were seen only in a subpopulation of
RyRN and RyRMH and usually in channels that showed
strong substate activity under control conditions (Fig. 11, A
and B). There was no consistent difference between RyRN
and RyRMH in substate levels or in the prolongation of
substates in the presence of the peptide. Thus an example
from one type of channel only is shown in Fig. 11. The
predominant substate level in the RyRMH channel in Fig. 11
was at 33% of the maximum conductance under control
conditions and the prolonged substate opening in the pres-
ence of 0.6 M peptide A was to the same level. This level
(arrow) is clearly seen in the all points histograms in Fig.
11, C and D. Twelve of 27 RyRN and 15 of 23 RyRMH
showed substate activity that was prolonged in the presence
of the peptide.
Effects of control peptides on single
channel activity
The specificity of the native sequence of peptide A was
examined by adding peptide NB or peptide AS to the cis
solution while recording activity from RyRN and RyRMH in
the presence of 10 M cis Ca2, where peptide A induced
the strongest activation. Peptide NB had no effect on RyRN
or RyRMH at either40 mV or40 mV (Fig. 12, A and B).
Peptide AS did not alter RyRN activity at 40 mV or 40
mV or RyRMH at 40 mV. Mean current increased by
FIGURE 11 Openings to submaximal conductance levels are prolonged
by peptide A. The recordings in (A) and (B) show 4 s of continuous
recording from an RyRMH channel at 40 mV with 10 M cis Ca2,
before (A) and after (B) addition of 0.6 M peptide A to the cis chamber.
The solid line (C) shows the zero current, closed level; the dotted line (S)
shows the dominant submaximal conductance level which is the same in
control activity and after peptide addition. The broken line (O) shows the
maximum open single channel conductance. (C) and (D) are all-points
histograms showing the probability (P) of current levels (I(pA)) for the
data in (A) and (B), respectively. The closed level at 0 pA is apparent in
both histograms. The submaximal level at 3.8 pA is indicated by the
arrow and is clearly enhanced after peptide A addition (D).
FIGURE 12 Control peptides NB and AS do not reproduce the effects of
peptide A on RyRN or RyRMH with 10 M cis [Ca2]. (A and B) Relative
mean current (Ip/Ic) for RyRN (left) and RyRMH (right) at 40 mV (A)
and 40 mV (B). Open circles show average data for peptide AS (n 	 3,
RyRN; n 	 4, RyRMH) and closed triangles show average data for peptide
NB (n 	 4, RyRN; n 	 5, RyRMH). The broken lines, included for
comparison, connect data for peptide A (from Figs. 5 and 6). Asterisks
indicate significant differences between either peptide NB or peptide AS
and peptide A at each concentration. (C) Effects on relative mean current
through RyRN (left) or RyRMH (right) of removing 30 M of peptides AS
or NB from the cis chamber. Average Ip/Ic is shown in the presence of
30 M peptide AS or NB (filled bins) and 3 to 5 min after removal of AS
or NB (cross-hatched bins). For comparison, the open bins show average
Ip/Ic before and after removal of 30 M peptide A (data from Fig. 7).
Asterisks indicate significant differences between control peptide (NB or
AS, data bins) and peptide A (open bins), under each condition.
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1.8-fold with 6 M AS at 40 mV, but this was signifi-
cantly less than the 7.5-fold increase seen with peptide A.
No significant washout activation was seen with NB or
with AS in RyRN or RyRMH at either 40 or 40 mV (Fig.
12 C). An increase in activity was, however, seen in 3 out
of 3 RyRMH channels at 40 mV after removal of AS, but
the average relative mean current of 4.6  1.4 was signif-
icantly less than the average of 11.2  1.2 seen after
washout of peptide A. When comparing AS or NB data with
peptide A data, the relative mean current at 40 mV was
significantly less both before and after washout of AS or NB
than before and after washout of peptide A.
Thus, the degree of activation of RyRN and RyRMH by
peptide A was a specific effect of the peptide and depended
on the sequence of amino acids in the peptide. The small
activation of single channels by the scrambled sequence AS
at high peptide concentrations is consistent with the small
increase in Ca2 release from SR vesicles evoked by the
peptide.
The experiments in Fig. 12 do not provide information on
the ability of the control peptides to inhibit RyR activity,
since inhibition is minimal when cis [Ca2] is 10 M (Fig.
8 and Dulhunty et al., 1999), but is significant with 100 M
cis Ca2. Therefore, inhibition by the control peptides was
examined in a separate series of experiments with 100 M
cis Ca2 and also 2 mM cis Na2ATP (which suppresses
activation, but not inhibition, by peptide A; see Results
above). Under these conditions, peptide NB failed to inhibit
either RyRN or RyRMH at either 40 mV or 40 mV
(Table 2). On the other hand, 6 M peptide AS inhibited
RyRMH at 40 mV, whereas 0.6 M and 6 M AS inhib-
ited RyRMH at 40 mV. Peptide AS did not alter activity in
RyRN. These results are consistent with a previous report
that AS can inhibit RyR activity (Dulhunty et al., 1999) and
confirm the observation that RyRMH is more susceptible
than RyRN to inhibition by positively charged peptides.
DISCUSSION
We show here that Ca2 release from the SR of MH-
susceptible pig skeletal muscle is more strongly activated by
the peptide A segment of the skeletal DHPR II-III loop than
Ca2 release from SR of normal pig muscle. In addition, the
peptide A-induced increase in RyR channel activity in lipid
bilayers was greater in RyRMH. These results suggest that
enhanced tension production (Gallant et al., 1980; Ohta et
al., 1989) in MH could, in part, be due to stronger activation
of RyRs by the A region of the DHPR II-III loop. This
would be consistent with observations that MH muscles are
more sensitive than normal to some, but not all, RyR ago-
nists, e.g., caffeine, halothane, and ryanodine (Mickelson
and Louis, 1996), but not sulfydryl oxidation (Haarmann et
al., 1999).
Activation by peptide A
MHmutations might influence relatively distant sites within
the RyR. Identified RyR-linked MH mutations occur in two
widely separated clusters: between N-terminal residues 35
and 615 (MH1 domain) and between residues 2163–2458
(MH2 domain; Tong et al., 1997). The only direct compar-
ison of mutations from these two domains found that the
physiological abnormalities were nearly identical (Richter
et al., 1997). It is possible that the MH domains of the RyR
are structurally important and/or have allosteric effects over
widespread areas of the RyR. The Arg615Cys substitution
could alter the conformation of the MH1 domain and its
interaction with other regions of the RyR or allosterically
alter the II-III loop binding site or the structure of regions
critical for transmission of information from the DHPR
binding region to the RyR ion channel pore.
It is not possible, from the present experiments, to dis-
tinguish among several likely mechanisms for stronger ac-
tivation of RyRs by peptide A. The MH mutation may alter
the peptide binding site on the RyR so that the peptide binds
more effectively and causes greater activation. A second
possibility is that the MH mutation facilitates transmission
of a signal from the remote cytoplasmic DHPR-binding
domain, presumably adjacent to the T-tubule membrane, to
the channel gating mechanism. Alternatively, the response
of the RyR gating mechanism to a signal from the binding
domain might be facilitated. In the last case, any activating
signal should induce a stronger response in RyRMH than in
RyRN. This is not the case, because the increase in activity
upon sulfhydryl oxidation is not greater in RyRMH (Haar-
mann et al., 1999).
TABLE 2 Peptide AS blocks RyRMH activity.
Peptide concentration n 0.6 M 3 M 6 M
Ip/Ic
40 mV
NB
RyRN 6 0.71  0.16 0.90  0.15 0.83  0.16
RyRMH 8 0.89  0.16 0.76  0.25 0.78  0.28
AS
RyRN 6 1.07  0.17 — 1.06  0.13
RyRMH 6 0.92  0.17 — 0.63  0.12
40 mV
NB
RyRN 6 1.58  0.44 1.61  0.51 1.36  0.42
RyRMH 8 0.86  0.45 0.74  0.25 0.96  0.29
AS
RyRN 6 0.82  0.18 — 0.56  0.14
RyRMH 6 0.45  0.09 — 0.35  0.12
Effects of peptides NB and AS on normalized average mean current
(Ip/Ic) for RyRN and RyRMH with 100 M cis Ca2 and 2 mM Na2ATP,
at 40 mV and 40 mV. Data are given as mean SEM. Bold print
indicates a significant (by Student’s t-test) decrease in mean current in the
presence of the peptide.
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We have suggested that the A region of the DHPR is
bound to the RyR in resting muscle (Dulhunty et al., 1999).
Increased resting activation of RyRMH by the A region in
vivo could contribute to enhanced Ca2-activated Ca2
release (Kim et al., 1984; Ohta et al., 1989; Mickelson et al.,
1988) and increased force (Gallant et al., 1980). If mecha-
nisms that lower myoplasmic [Ca2] are unable to cope
with the high Ca2 leak, resting cytoplasmic [Ca2] would
also be higher than normal (Lopez et al., 1986).
The scrambled peptide AS released Ca2 from SRMH,
and from rabbit skeletal SR, at a lower rate than the native
peptide A (Dulhunty et al., 1999) and enhanced RyRMH
activity. Since peptide AS contains the same number of
positively charged residues as peptide A, it is likely that it
interacts weakly with the A-binding region on the RyR, but
cannot interact strongly because it lacks the appropriate
structure (Casarotto et al., 2000).
Inhibition
Inhibition by high concentrations of the peptide A at 40
mV was enhanced by the MH mutation. The voltage and
current direction dependence of inhibition suggest that the
peptide blocks the channel pore (Dulhunty et al., 1999) as a
result of strong interactions between its numerous positively
charged residues and negative sites within the pore (Mead et
al., 1998). In contrast, activation is likely to depend on
peptide binding to a II-III loop binding-site on the RyR. The
enhanced inhibition of RyRMH could be due to a greater
negative charge density in the channel vestibule as result of
the Arg615Cys substitution. Alternatively, the geometry of
the vestibule might change to allow the peptide greater
accessibility. In either case, the results show that the MH
mutation changes more than one property of the RyR and
underlines the importance of the MH domains in influenc-
ing the structure of the entire RyR. The MH mutation in the
N-terminal part of the RyR alters the properties of C-
terminal residues, which form the channel pore (Bhat et al.,
1997).
Inhibition by peptide A was not apparent in Ca2 release
from SRN and SRMH and is not apparent in Ca
2 release
from rabbit skeletal SR (Dulhunty et al., 1999). Inhibition is
minimal in these experiments where ion flow is from the SR
lumen into the cytoplasm. Inhibition is strongest when ions
flow from the cytoplasm to the lumen (i.e., 40 mV). It is
unlikely that inhibition occurs in vivo where the II-III loop
is tethered to the DHPR in the T-tubule membrane well
away from the RyR pore.
Multiple effects of the MH mutation
In addition to effects of the MH mutation on activation and
inhibition by peptide A, the Arg615Cys substitution is asso-
ciated with a reduced affinity of RyRMH for Ca
2 (Fill et al.,
1991; Shomer et al., 1993; Richter et al., 1997) or Mg2
(Laver et al., 1997) at a low affinity inhibitory site. We did
not use [Ca2] in the inhibitory range (100 M), so did
not observe this difference between RyRMH and RyRN.
Mg2 inhibition is thought to play a critical role in EC
coupling in that the RyR is chronically inhibited at myo-
plasmic [Mg2]. Ca2 release during EC coupling proceeds
because the EC coupling signal from the DHPR reduces the
affinity of the RyR for Mg2 (Lamb and Stephenson, 1991).
The lower than normal affinity of RyRMH for Mg
2 means
that RyR activity is higher than normal and may be en-
hanced more than normal during EC coupling (Laver et al.,
1997). The Ca2/Mg2 inhibition site has been located on
the C-terminal portion of the RyR (3692 to 4969, Lynch et
al., 1999), and changes to this site might be related to
changes in the channel region that lead to enhanced inhibi-
tion by peptide A. Involvement of the C-terminal Mg2-
inhibition region further emphasizes the wide-spread influ-
ence of the MH domain on RyR structure and function.
As mentioned previously, it is not clear whether the MH
mutation increases the ability of all activating agents to
enhance channel activity by altering a common site in the
activation process or whether the mutation causes multiple
changes in ligand binding sites or links between the binding
sites and the channel pore. Both activation by relief of Mg2
inhibition (with reduced [Mg2]) and by caffeine are en-
hanced in MH, suggesting that both physiological and non-
physiological activators may share a common activation
mechanism. On the other hand, physiological activation by
sulfhydryl oxidation is not enhanced in MH (Haarmann et
al., 1999), so that the common mechanism is not shared by
all activating influences. Thus, the question remains open
whether peptide A is a physiological or a nonphysiological
activator of the RyR channel, since the A region is not
essential for skeletal EC coupling (Nakai et al., 1998, 2000).
The peptide, however, has several merits as a probe for
studying normal and disordered RyR activity, including its
high affinity and specific binding to the calcium release
channel.
Peptide A-evoked Ca2 release from
normal pig SR
The low Ca2 release from SRN induced by peptide A was
unexpected, since EC coupling and contraction in pig mus-
cle proceed as effectively as in rabbit muscle (Gallant et al.,
1980). In contrast to Ca2 release, activation of single pig
RyRN channels by peptide A was similar to activation of
rabbit RyRs (Dulhunty et al., 1999). Ca2 release from the
SR was, of necessity, measured in the presence of ATP,
which prevented peptide A activation of single pig RyR
channels (Results). Thus ATP may have suppressed Ca2
release from pig SR. We are further investigating this effect
of ATP on peptide A activation of pig RyRs.
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There are several possible reasons for the difference
between peptide A-induced activation of normal pig and
rabbit RyRs. Rabbit and pig RyRs differ by one amino acid
in the RyR sequence required for DHPR II-III loop binding
with Thr1082Ala substitution in the pig (Fujii et al., 1991;
Takeshima et al., 1989). First, this difference may destabi-
lize peptide A binding and reduce in vitro peptide A acti-
vation of normal pig RyRs (in vivo, the RyR-DHPR loop
interaction could be stabilized by the spatial constraints
imposed by insertion of the two large proteins in their
respective membranes). Second, the sequence differences
between normal pig and rabbit RyRs may mean that addi-
tional cytosolic factors are necessary for effective peptide
A, or A region of the II-III loop, binding to the RyR in
normal pig muscle. Finally, there maybe be changes in the
porcine II-III loop sequence that accommodate and stabilize
binding to the porcine RyRN. A number of species-specific
sequence differences occur in the DHPR II-III loop, al-
though the pig sequence is not yet reported (Tanabe et al.,
1987; Hogan et al., 1994; Chaudhari, 1992). In any case,
the lack of peptide A sensitivity of normal pig RyRs in vitro
in the presence of ATP is partially reversed by the MH
mutation.
In conclusion, we find that RyR channels from MH-
susceptible pig muscle are more easily activated by peptide
A than RyR channels from normal pigs, in the absence of
Mg2 or inhibiting concentrations of cytoplasmic Ca2.
The channels from MH-susceptible muscle are also inhib-
ited more by high concentrations of the positively charged
peptide. The results suggest that activation by the DHPR
II-III loop might be enhanced during EC coupling and
contribute to an increase in Ca2 release from the SR of
MH-susceptible muscle. In addition, the results show that
the MH point mutation alters the response of the RyR to
more than one ligand, and thus has multiple actions on the
RyR.
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